GM1 Antibody
The GM1 antibody test measures the presence and levels of antibodies against the ganglioside GM1 in the blood, which are often associated with certain neurological disorders.
GM1 antibody levels help diagnose neurological conditions like multifocal motor neuropathy.
Key facts at a glance
- Units
- titer
- Clinical utility
- diagnostic
- Result kind
- qualitative
- FDA-cleared
- Roche Anti-GM1, Athersys GM1 Ab
GM1 ganglioside is a component of cell membranes, particularly abundant in the nervous system. Antibodies against GM1 can disrupt nerve function and are often found in patients with neurological autoimmune disorders.
The GM1 antibody test is primarily used to aid in the diagnosis of conditions such as multifocal motor neuropathy (MMN) and lower motor neuron disease. Elevated levels of these antibodies can support a diagnosis when clinical symptoms are present.
A titer of ≤1 is considered the reference range for normal levels of GM1 antibodies. Higher titers may indicate the presence of an underlying neurological condition that requires further investigation.
Frequently asked questions
What is the purpose of the GM1 antibody test?
What does a high GM1 antibody titer mean?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy